Clevergene Biocorp, a deep-tech genomics company, has signed a Memorandum of Understanding (MoU) with The Rajiv Gandhi Centre for Biotechnology (RGCB), to establish a state-of-the-art genomics centre at Thiruvananthapuram. 

In a first of its kind in Kerala, the state-of-the-art genomics centre will house the latest DNA sequencing equipment like the Illumina NovaSeq and other allied infrastructure to support cutting-edge research in plant biotechnology, infections, cancer and other chronic diseases. 

The services of this high-throughput genomics centre will be open for use in research to other institutes and industries and will provide services like gene expression analysis, epigenetics and genome analysis including that of the COVID-19 virus. 

The MoU was represented by Professor Chandrabhas Narayana, Director, RGBC, S Mohanan Nair, Chief Controller, RGBC Dr TR Santhosh Kumar and Tony Jose, CEO, Clevergene Biotech and Shiv Mohan Singh Chief Commercial Officer, Clevergene Biotech.